Medical imaging and radiology
Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryLunit medical AI product profile
Cancer-focused medical AI company with imaging and precision-oncology products spanning Lunit INSIGHT and Lunit SCOPE workflows.
Medical imaging and radiology
Best fit
Organizations evaluating cancer-screening AI, mammography or chest X-ray support, and oncology research workflows that need product-specific regulatory review.
- Primary use case
- AI cancer screening, breast imaging, chest X-ray, precision oncology, and pathology biomarker workflows
- Audience
- Radiology, breast imaging, oncology, pathology, clinical-trial, and cancer-screening teams
- Risk level
- High
- Pricing signal
- Enterprise, regional, and product-specific pricing; request current module and deployment terms.
- Official sources
- 3 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Lunit as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify the exact Lunit product, version, modality, anatomy, and intended use against FDA, CE/MDR, and local product-registration materials before clinical deployment. |
|---|---|
| Privacy | Review image routing, cloud or partner integrations, retention, access controls, DICOM metadata handling, security documentation, and any research or training-data terms. |
| Evidence | Require module-level validation for the local population and scanner workflow rather than relying on platform-level publication or site-count claims. |
| Workflow | Map radiologist, breast-imaging, pathology, oncology, PACS/RIS, and escalation workflows separately because Lunit's product family spans multiple clinical pathways. |
Where Lunit fits
Lunit describes a cancer AI ecosystem spanning screening, diagnosis, treatment decisions, and drug development, including Lunit INSIGHT radiology products and Lunit SCOPE precision-oncology and pathology products; FDA-listed records and Lunit regulatory pages should be checked for product-specific status.
Not for: Using a broad platform claim as authorization for every Lunit module, geography, modality, scanner, or diagnostic use case.
What to verify before using Lunit
- Which module is in scope: INSIGHT MMG, INSIGHT DBT, INSIGHT CXR, SCOPE IO, SCOPE IHC, SCOPE GP, or a Volpara-derived workflow.
- FDA, CE/MDR, local regulatory, product-registration, and intended-use status for the exact geography and version.
- PACS, mammography, CXR, pathology, oncology, reporting, and partner-platform integration requirements.
- Validation evidence for the target modality, population, scanner mix, cancer pathway, false positives, false negatives, and clinical monitoring plan.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.lunit.io / en
- www.lunit.io / en / technology
- www.fda.gov / medical-devices / software-medical-device-samd
Related medical AI products
Medical imaging and radiology
Viz.ai
AI-powered care coordination platform with imaging-driven alerts across therapeutic areas.
Medical imaging and radiology
Ferrum Health
Clinical AI governance and deployment platform for health systems adopting multiple imaging or clinical AI models.
Medical imaging and radiology
Blackford Platform
Enterprise medical imaging AI platform for evaluating, deploying, routing, and monitoring multiple radiology AI applications.